Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
BRIACELL THERAP (BCTX) had Weighted-Average Shares Outstanding (Diluted) of 2.70M for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
-- |
|
$-6.29M |
|
-- |
|
-- |
|
$7.17M |
|
$-7.17M |
|
$0.83M |
|
$-6.34M |
|
$-6.34M |
|
$-6.34M |
|
$-6.34M |
|
$-6.34M |
|
$-6.34M |
|
$-7.17M |
|
$-7.14M |
|
2.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.70M |
$-2.33 |
|
$-2.33 |
|
| Balance Sheet Financials | |
$7.16M |
|
$0.34M |
|
$2.20M |
|
$9.36M |
|
$5.23M |
|
-- |
|
$0.91M |
|
$6.14M |
|
$3.23M |
|
$3.03M |
|
$3.23M |
|
2.95M |
|
| Cash Flow Statement Financials | |
$-12.88M |
|
$-0.15M |
|
$17.18M |
|
$0.86M |
|
$5.01M |
|
$4.15M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-196.41% |
|
-208.84% |
|
-67.69% |
|
-196.41% |
|
$1.09 |
|
$-4.77 |
|
$-4.77 |
|